ISSN 0975-3583

Journal of Cardiovascular Disease Research

    Role Of Vitamin D Supplementation Along with Betahistine Alone in Patients of Benign Paroxysmal Positional Vertigo: A One Year Randomized Controlled Trial

    Dr. Udbhav Mittal, Dr. Vipin Saigal, Dr. Neha Raghava
    JCDR. 2019: 174-178


    Benign paroxysmal positional vertigo (BPPV) poses a significant public health concern, affecting approximately 10% of the general population. Although considered benign, BPPV profoundly impacts quality of life. Current therapeutic maneuvers primarily focus on physical repositioning techniques, prompting exploration into pharmacological adjuncts. Vitamin D's role in calcium homeostasis and inner ear function, coupled with Betahistine's vasodilatory effects, led to the investigation of their combined efficacy in BPPV management. Materials and Methods: A one-year randomized controlled trial, enrolled 120 BPPV patients, aged 18-65 years. Participants were randomly assigned to Group A (Vitamin D supplementation + Betahistine) or Group B (Betahistine alone). Outcome measures included vertigo episode reduction, balance improvement, quality of life enhancement, and recurrence rates. Statistical analyses employed descriptive statistics, t-tests, chi-square tests, and Kaplan-Meier survival analysis.


    » PDF

    Volume & Issue

    Volume 10 Issue 1